PMC:7283670 / 67889-68147
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T381 | 14-22 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T382 | 67-75 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T601 | 86-88 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T222 | 128-133 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T223 | 155-165 | Chemical | denotes | fingolimod | http://purl.obolibrary.org/obo/CHEBI_63115 |
| T224 | 176-181 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T225 | 202-212 | Chemical | denotes | fingolimod | http://purl.obolibrary.org/obo/CHEBI_63115 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T660 | 0-258 | Sentence | denotes | Fingolimod in COVID‐19 Biological: UC‐MSCs, other: placebo China/COVID‐19 30, all, 18–80 Treatment Experimental: treatment group: each patient in the fingolimod treatment group was given 0.5 mg of fingolimod orally once daily, for three consecutive days |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1905 | 140-147 | Species | denotes | patient | Tax:9606 |